Skeletal/Connective Tissue Cells TRIZ Cases

Segmenting TCF21-high and TCF21-low subpopulations prevents fibrosis while promoting functional heart tissue regeneration.

Immortalized clonal mesenchymal stem cell lines generate standardized extracellular vesicles.

Pre-seeded stem cells on a cross-linked polymer scaffold bridge large nerve gaps while eliminating foreign body reactions.

Defined Activin A and BMP conditions polarize hPSCs toward anterior cardiogenic mesoderm, eliminating post-facto enrichment steps that reduce yield.

Stem cell-seeded scaffolds promote bone healing while eliminating donor site morbidity from autografts.

A substrate assembly uses edible fibres with internal channels to support cell culture and enable fluid communication across the structure.

Differentiating induced pluripotent stem cells into fibroblasts produces purified extracellular matrix without animal-derived contaminants.

Targeted amino acid substitutions create thermostable FGF-1 variants that maintain pluripotency at lower concentrations, reducing culture costs.

Antibody-based separation isolates mesenchymal stem cells from cord blood samples for subsequent culture.

Lentiviral transduction revitalizes mesenchymal stem cells, resolving niche factor loss during culture to expand hematopoietic stem cell numbers.

FGF-8 primed stem cells direct differentiation toward cardiac lineages, resolving uncertainty in optimal cell type selection.

Segmenting pluripotent stem cell culture into suspension and adhesion stages resolves reproducibility issues while maintaining manageable process complexity.

Metamizole-treated mesenchymal stem cells accelerate new blood vessel growth.

Silicate-induced extracellular vesicles accelerate wound healing by boosting protein content, overcoming limited efficacy in chronic conditions.

Sintered fluoridated apatite scaffolds embed metal substitutes to resolve insufficient bone integration and infection risks in dental implants.

Applying timed SIRT1 modulators resolves the trade-off between differentiation precision and pathway flexibility.

Conditioned medium from Spalax fibroblasts isolates bioactive fractions that selectively kill cancer cells while sparing normal tissue.

Autologous fibrin scaffold with patient-derived cells recreates the 3D bone marrow microenvironment, enabling personalized drug screening.

Hemispherical microwell culture overcomes low adult stem cell differentiation efficiency into parathyroid cells, boosting hormone production.

Pre-expanded allogeneic cardiosphere-derived cells enable immediate treatment while reducing immune rejection.

Transient microRNA-203 exposure expands differentiation potential and efficiency of pluripotent cells while maintaining self-renewal.

Elevated support structure facilitates air circulation and nutrient supply for accurate biomimetic drug screening models.

Coculturing regulatory T cells with adipose stem cells enhances immunosuppressive potential through direct cell-to-cell contact.

Amniotic fluid cell-derived extracellular matrix replicates native microenvironment cues to resolve fidelity versus simplicity trade-offs in stem cell culture.

A hydrogel scaffold binds disulfide flavor compounds to release meaty aromas during cooking, replicating Maillard reaction profiles.

Transmembrane TNF activates TNFR2 on stem cells to generate T cell precursors while preserving self-renewal capacity.

Stacking aligned cell sheets onto flexible thermoresponsive substrates creates complex 3D tissues with controlled anisotropic architecture.

STRO-1+ cell preparations reduce eosinophil levels to address corticosteroid-resistant asthma inflammation.

A multilayered cell sheet serves as a localized platform for oncolytic adenoviruses to replicate and act directly at tumor sites.

Isolating urine stem cells and directing their lineage commitment via parameter changes to supply abundant, versatile cells for tissue repair.

Pre-treat stem cell-derived cardiomyocytes with antiarrhythmic agents to modify gene expression and reduce independent contraction.

Sorting selects robust mesenchymal stromal cells via SUSD2 markers, resolving the contradiction between cell expansion and aging profiles.

A cardiovascular graft uses mesenchymal stem cells modified to reduce telomerase reverse transcriptase expression for tissue engineering.

Porous scaffold embeds endothelial cells and fibroblasts to support vascular pedicle integration, resolving donor organ shortages.

A method reprogramming oral epithelial cells into dental tissue using de-differentiation and conversion agents.

Upregulating CD55 on mesenchymal stem cells via pharmacological intervention to enhance cell survival and engraftment potential.

Lnc4047 inhibits myoblast proliferation while promoting differentiation, resolving the trade-off between growth rate and meat quality.

Overexpressing Id and Evx proteins resolves fragmented knowledge gaps to generate multipotent cardiovascular progenitors.

De-cellularized bone-like material eliminates donor site morbidity while providing rapid host tissue integration for spinal fusion procedures.

Removing PTPσ+ cells via flow cytometry sorting enhances repopulating capacity and engraftment efficiency for bone marrow reconstitution.

Metal-organic frameworks coat cardiomyocytes to resolve physical protection and nutrient supply contradictions, extending cell lifespan.

A stem cell-based microfluidic lung device differentiates patient cells into functional tissue structures.

Identifying cardiac progenitor cells through phospho-Rb fluorescence enables precise isolation and regeneration prediction.

A chitin nanofiber substrate carrying vitronectin enables suspension culture of adherent cells without stirring.

Co-culturing stem cells with adipocyte-isolated NK cells drives efficient differentiation into clinically safe therapeutic agents.

MIC-1 stem cell line derived from deer antlers regenerates connective tissue.

Cryopreserved Wharton's jelly MSCs address septic shock by retaining post-thaw immunomodulatory and antibacterial properties to reduce inflammation.